Overview

Effects of Mepolizumab Compared to Placebo on Airway Physiology in Patients With Eosinophilic Asthma: MEMORY Study

Status:
Terminated
Trial end date:
2017-05-22
Target enrollment:
Participant gender:
Summary
The purpose of the MEMORY trial is to compare the effects of mepolizumab with Placebo on airway physiology in patients with eosinophilic asthma
Phase:
Phase 3
Details
Lead Sponsor:
Johannes Gutenberg University Mainz
Collaborator:
GlaxoSmithKline